NewLimit, a 1.5-year-old, San Francisco-based, 17-person company that aims to increase the number of healthy years each person lives by epigenetically reprogramming cells, is today announcing that ...

NewLimit Inc., South San Francisco, $40 million, Series A: Dimension, Founders Fund and Kleiner Perkins invested in this developer of cell-based treatments to extend lifespans co-founded by ...

NewLimit valuation hits $810 million after Series B funding round - Bloomberg ...

Coinbase CEO Brian Armstrong has introduced NewLimit, a company he's helping build as a board member and investor in the epigenetic reprogramming space. The mission of NewLimit is to radically ...

NewLimit, a 1.5-year-old, San Francisco-based, 17-person company that aims to increase the number of healthy years each person lives by epigenetically reprogramming cells, is today announcing that it ...